There was no significant difference in the expression levels of CBR1, CCDC102A, LGALS1, SLC29A2, RD3L and TWIST1 genes between AML patients and healthy donors (Supplementary Figure 9). This evidence concerns the gene CCDC102A and acute myeloid leukemia.